Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery
Conditions: Diabetic Macular Edema; Cataract Intervention: Drug: Bevacizumab Injection Sponsors: Los Angeles Biomedical Research Institute; Allergan; Doheny Image Reading Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Avastin | Cataract Removal | Cataracts | Dexamethasone | Diabetes | Endocrinology | Research